![Image](https://www.envolbio.com/wp-content/uploads/2023/11/Untitled-design-8.png)
Pharmacology and Toxicology Research for Drug Development and Discovery
Envol Biomedical is a leading nonclinical laboratory offering pharmacology and toxicology capabilities focused on non-human primates.
Access to the largest population of readily available naïve and non-naïve non-human primates (old-world and new-world) in the continental U.S.
Dedicated to providing cost-effective studies with extremely fast turn-around time.
Dedicated to the on-time delivery of study samples and study reports (standard and specific study protocols).
AAALAC accredited, USDA and OLAW compliant.
Learn More
Why Choose Envol Biomedical?
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-01.png)
Non-human primate preclinical research
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-05.png)
Largest population available in the continental U.S.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-08.png)
On time delivery of study samples and study reports
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-11.png)
AAALAC accredited, USDA and OLAW compliant
Our Capabilities
Envol Biomedical is a leading nonhuman primate research facility that builds on over 20 years of primate capabilities. Our strategy is to 1) create an exceptional team, 2) foster a successful culture, and 3) focus on our clients. Our team applies cutting-edge pharmacology and surgical models to facilitate drug development, primarily in the areas of gene targeting and biologics. We provide pharmacokinetics, pharmacodynamics, and toxicology research to help advance technologies with best-in-class capabilities. The best way to learn about our capabilities is to come visit the laboratory. We look forward to seeing you.We specialize in analyzing drug absorption, distribution, metabolism, and excretion to guide dosing strategies for safe and effective treatments.
Our in-depth understanding of how drugs interact with the body enables precise assessment of their effects, crucial for optimizing therapeutic outcomes.
With a focus on safety, we meticulously evaluate the potential harm of substances, ensuring they meet stringent regulatory standards.
News & Insights
June 28, 2024
Building a non-clinical, non-human primate (NHP) CRO around your needs
My name is Jake McDonald, CEO of Envol Biomedical. I joined the company last fall...June 20, 2024
Dr. Jake McDonald presents on the FDA Modernization ACT and 3Rs at the Society of Toxicologic Pathology annual symposium
Joining colleagues from the pharmaceutical industry, Dr. McDonald kicked off a session on the FDA...May 15, 2024
Envol Biomedical: Contract Research Laboratories’ Unparalleled Access to Nonhuman Primates Facilitates Meeting Customer Biomedical Research Needs
Envol Biomedical is a specialty drug development nonclinical contract research laboratory focused on the use...Talk to an Expert About Our Research & Services
For inquiries about our research and services, don't hesitate to get in touch with our experts. Your journey to innovation starts here.